In vitro inhibition of HIV‐1 proteinase by cerulenin

Retroviruses encode proteinases necessary for the proteolytic processing of the viral gag and gag‐pol precursor proteins. These enzymes have been shown to be structurally and functionally related to aspartyl proteinases such as pepsin and renin. Cerulenin is a naturally occurring antibiotic, commonly used as an inhibitor of fatty acid synthesis. Cerulenin has been observed to inhibit production of Rous sarcoma virus and murine leukaemia virus by infected cells, possibly by interfering with proteolytic processing of viral precursor proteins. We show here that cerulenin inhibits the action of the HIV‐1 proteinase in vitro, using 3 substrates: a synthetic heptapeptide (SQNYPIV) which corresponds to the sequence at the HIV‐1 gag junction, a bacterially expressed gag precursor, and purified 66 kDa reverse transcriptase. Inhibition of cleavage by HIV‐1 proteinase required preincubation with cerulenin. Cerulenin also inactivates endothiapepsin, a well‐characterised fungal aspartyl proteinase, suggesting that the action of cerulenin is a function of the common active site structure of the retroviral and aspartic proteinases. Molecular modelling suggests that cerulenin possesses several of the necessary structural features of an inhibitor of aspartyl proteinases and retroviral proteinases. Although cerulenin itself is cytotoxic and inappropriate for clinical use, it may provide leads for the rational design of inhibitors of the HIV proteinase which could have application in the chemotherapy of AIDS.

[1]  Tom Blundell,et al.  The active site of aspartic proteinases , 1991, FEBS letters.

[2]  J. Harley,et al.  Effects of inhibitors of lipid synthesis on the replication of Rous sarcoma virus. A specific effect of cerulenin on the processing of major non-glycosylated viral structural proteins. , 1978, Biochimica et biophysica acta.

[3]  J. Whitaker.  [29] Protease of Endothia parasitica , 1970 .

[4]  L. Pearl,et al.  The catalytic mechanism of aspartic proteinases , 1987, FEBS letters.

[5]  S Omura,et al.  Inhibition of fatty acid synthesis by the antibiotic cerulenin. Specific inactivation of beta-ketoacyl-acyl carrier protein synthetase. , 1973, Biochimica et biophysica acta.

[6]  D. Davies,et al.  Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution. , 1982, Biochemistry.

[7]  E. Padlan,et al.  Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Hansen,et al.  RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus. , 1987, The Journal of biological chemistry.

[9]  K. Ikuta,et al.  The effect of cerulenin on the synthesis of the precursor gag polyprotein in defective murine leukemia and sarcoma virus producing cell lines. , 1986, Virology.

[10]  P. Štrop,et al.  Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. , 1988, The Journal of biological chemistry.

[11]  K. Ikuta,et al.  Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin. , 1986, Virology.

[12]  T. Copeland,et al.  Synthetic non-peptide inhibitors of HIV protease. , 1989, Biochemical and biophysical research communications.

[13]  J. Tang,et al.  Specific and irreversible inactivation of pepsin by substrate-like epoxides. , 1971, The Journal of biological chemistry.

[14]  William R. Taylor,et al.  A structural model for the retroviral proteases , 1987, Nature.

[15]  I. Katoh,et al.  Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Hansen,et al.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. , 1988, The EMBO journal.

[17]  M. James,et al.  Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin , 1977, Nature.

[18]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[19]  C. Debouck,et al.  Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Moelling.  Reverse transcriptase and RNase H: present in a murine virus and in both subunits of an avian virus. , 1975, Cold Spring Harbor Symposia on Quantitative Biology.

[21]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[22]  K. Rock,et al.  Cerulenin is a potent inhibitor of antigen processing by antigen-presenting cells. , 1987, Journal of immunology.

[23]  R. Gallo,et al.  Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. James,et al.  Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin. , 1985, Biochemistry.

[25]  H. Varmus,et al.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.

[26]  B. Larder,et al.  AIDS virus reverse transcriptase defined by high level expression in Escherichia coli. , 1987, The EMBO journal.

[27]  M. James,et al.  Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Stammers,et al.  HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis. , 1988, Biochemistry.

[29]  K. Helm.  Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15 Iviral precursor polypeptide/group-specific (gs) antigen/in vitro proteolytic cleavage process) , 1977 .

[30]  B. Dunn,et al.  The pH dependence of the hydrolysis of chromogenic substrates of the type, Lys-Pro-Xaa-Yaa-Phe-(NO2)Phe-Arg-Leu, by selected aspartic proteinases: evidence for specific interactions in subsites S3 and S2. , 1987, Biochimica et biophysica acta.

[31]  M. Schlesinger,et al.  Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation. , 1982, The Journal of biological chemistry.